Baird Capital

Venture Capital Firm

Baird Capital

Baird Capital makes venture capital, growth equity, and private equity investments in strategically targeted sectors around the world. Baird Capital’s venture team invests in early and expansion stage technology-enabled B2B services and healthcare companies. Having invested in more than 300 companies over its history, Baird Capital partners with entrepreneurs and leverages its executive networks to build exceptional companies. The venture team has partnered with many of today’s leading emerging businesses in the targeted sectors, including such companies as Accuri Cytometers, Interlace Medical, MI Bioresearch, NeuMoDx Molecular, Autobooks, and Strata Oncology.



  • Jim Pavlik
    Partner, Baird Capital
  • Benedict Rocchio
    Partner, Baird Capital
  • Mike Liang
    Partner, Baird Capital
  • Joanna Linsley
    Senior Associate, Baird Capital
  • Kathleen Schultze
    Operations Associate , Baird Capital
  • Don Layden
    Venture Partner, Baird Capital
  • Joanna Arras
    Principal, Baird Capital

Stages of Investment

  • Growth/Expansion

Sectors of Investment

  • Business Services
  • Mobility

IT Subsectors

  • Services
  • Software

Life Science Subsectors

  • Devices
  • Diagnostics
  • Healthcare Services


  • Assets Under Management $460,000,000

The most timely & relevant email you will get about Michigan’s investment & entrepreneurial ecosystem.

From public policy to the new ideas and breakthrough investment opportunities, MVCA will keep your finger on the pulse of must know information in the industry.


This field is for validation purposes and should be left unchanged.